Web Analytics

3 Latest Announced Rounds

  • $12,000,000
    Unknown

    3 Investors

    Hospital & Health Care
    Jun 4th, 2025
  • Undisclosed Amount
    Series A

    4 Investors

    Biotechnology Research
    Jun 4th, 2025
  • $21,000,000
    Unknown
    Software Development
    Jun 4th, 2025
$849.58M Raised in 57 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Angitia Biopharmaceuticals

start up
United States - Woodland Hills, CA
  • 12/12/2024
  • Series C
  • $120,000,000

Angitia is a clinical-stage biotechnology company focused on discovering and developing breakthrough therapeutics that address the key unmet medical needs of serious musculoskeletal diseases. With the team’s experience and scientific expertise in new drug development, Angitia is dedicated to bringing innovative therapeutics to help patients in need.


Related People

Hua Zhu (David) KeFounder

Hua Zhu (David) Ke United States - Greater Los Angeles, California

Discovery and translational research professional, specifically in bone and renal diseases.